Literature DB >> 16548895

Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.

Danelle S Eto1, Jamie L Sundsbak, Matthew A Mulvey.   

Abstract

Strains of uropathogenic Escherichia coli (UPEC) can invade terminally differentiated superficial bladder epithelial cells and subsequently multiply, forming large biofilm-like inclusions referred to as pods. In contrast, within immature bladder cells UPEC enter a more quiescent state and often fail to replicate appreciably. As immature bladder epithelial cells undergo terminal differentiation the actin cytoskeleton is radically diminished, a phenomenon that we reasoned could influence the intracellular fate of UPEC. Here we show that UPEC within undifferentiated bladder cells is trafficked into acidic compartments having key features of late endosomes and lysosomes. These UPEC-containing vacuoles are often enmeshed within a network of actin filaments, the disruption of which stimulates intravacuolar growth and efflux of UPEC in cell culture-based studies. In this in vitro model system, release of UPEC into the host cytosol further stimulates intracellular bacterial growth and the rapid development of pod-like inclusions. These inclusions, as well as those observed using an in vivo mouse model, develop in association with cytokeratin intermediate filaments that may act as scaffolding for intracellular biofilm formation. Our data suggest an aetiological basis for recurrent urinary tract infections, linking bladder cell differentiation and the accompanying redistribution of actin microfilaments with the resurgence of UPEC from quiescent intravacuolar reservoirs within the bladder epithelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548895     DOI: 10.1111/j.1462-5822.2006.00691.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  63 in total

1.  Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.

Authors:  Luke P Allsopp; Christophe Beloin; Glen C Ulett; Jaione Valle; Makrina Totsika; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

4.  Androgens Enhance Male Urinary Tract Infection Severity in a New Model.

Authors:  Patrick D Olson; Keith A Hruska; David A Hunstad
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

5.  Antibacterial effects of nitric oxide on uropathogenic Escherichia coli during bladder epithelial cell colonization--a comparison with nitrofurantoin.

Authors:  Ravi Vumma; Charlotte Sahlberg Bang; Robert Kruse; Kjell Johansson; Katarina Persson
Journal:  J Antibiot (Tokyo)       Date:  2015-11-04       Impact factor: 2.649

Review 6.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

7.  Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.

Authors:  Indira U Mysorekar; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

Review 8.  TLR-mediated immune responses in the urinary tract.

Authors:  Jeongmin Song; Soman N Abraham
Journal:  Curr Opin Microbiol       Date:  2008-02-01       Impact factor: 7.934

9.  Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Authors:  Richard R Kulesus; Karen Diaz-Perez; E Susan Slechta; Danelle S Eto; Matthew A Mulvey
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

Review 10.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.